Most strikingly, these studies indicated that upregulated PD-L1 on lung fibroblasts entitled an invasive phenotype to fibroblasts, thereby promoting IPF progression, and anti-PD-L1 monoclonal antibody (anti-PD-L1 mAb) could reverse this effect. The gene discussed is CD274; the disease is idiopathic pulmonary fibrosis.